Galnts as modifiers of the igfr pathway and methods of use

C - Chemistry – Metallurgy – 12 – P

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12P 21/06 (2006.01) C12P 21/04 (2006.01) C12Q 1/48 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01)

Patent

CA 2571250

Human GALNT genes are identified as modulators of the IGFR pathway, and thus are therapeutic targets for disorders associated with defective IGFR function. Methods for identifying modulators of IGFR, comprising screening for agents that modulate the activity of GALNT are provided.

Des gènes GALNT humains sont identifiés comme modulateurs du chemin IGFR, et sont ainsi des cibles thérapeutiques pour des troubles associés à une fonction IGFR défectueuse. La présente invention concerne donc des procédés permettant d'identifier des modulateurs d'IGFR, avec recherche par criblage d'agents modulant l'activité de GALNT.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Galnts as modifiers of the igfr pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Galnts as modifiers of the igfr pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galnts as modifiers of the igfr pathway and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1835568

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.